Last year at this time, I made a screen of some stocks from the healthcare sector with an interesting market valuation, a great past growth performance as well as good earnings situation. Such stocks had a forward price to earnings ratio of less than 15, a sales growth over the past five years of more than 10 percent as well as an operating margin above 10 percent. Exactly seven stocks fulfilled these criteria. Now, I review these picks and try to discover a new list of potential stocks for next year, 2013. Over the recent year the Dow is up 8.36 percent, the S&P 500 gained 13.82 percent and the NASDAQ is 14.58 percent higher. My seven healthcare picks performed in average 31.55 percent while the healthcare sector gained 25.7 percent. Below is a current screen of the seven picks.

Abbott Laboratories (NYSE:ABT) is engaged in discovery, development, manufacture, and sale of diversified line of healthcare products. Abbott Laboratories achieved its new price of $57.20 where it was opened at $57.15 down -0.43 points or -0.75% by closing at $56.61. ABT transacted shares during the day were over 8.10 million shares however it has an average volume of 7.27 million shares.

Abbott Laboratories (NYSE:ABT) is engaged in discovery, development, manufacture, and sale of diversified line of healthcare products. Abbott Laboratories achieved its new 52 week high price of $56.74 where it was opened at $56.33 up 0.41 points or 0.73% by closing at $56.70.